BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 14742601)

  • 1. A novel mutation of myelin protein zero associated with an axonal form of Charcot-Marie-Tooth disease.
    Santoro L; Manganelli F; Di Maria E; Bordo D; Cassandrini D; Ajmar F; Mandich P; Bellone E
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):262-5. PubMed ID: 14742601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid progression of late onset axonal Charcot-Marie-Tooth disease associated with a novel MPZ mutation in the extracellular domain.
    Laurà M; Milani M; Morbin M; Moggio M; Ripolone M; Jann S; Scaioli V; Taroni F; Pareyson D
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1263-6. PubMed ID: 17940173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
    Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
    Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth disease: a novel Tyr145Ser mutation in the myelin protein zero (MPZ, P0) gene causes different phenotypes in homozygous and heterozygous carriers within one family.
    Leal A; Berghoff C; Berghoff M; Del Valle G; Contreras C; Montoya O; Hernández E; Barrantes R; Schlötzer-Schrehardt U; Neundörfer B; Reis A; Rautenstrauss B; Heuss D
    Neurogenetics; 2003 Aug; 4(4):191-7. PubMed ID: 12845552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
    Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
    Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype.
    De Jonghe P; Timmerman V; Ceuterick C; Nelis E; De Vriendt E; Löfgren A; Vercruyssen A; Verellen C; Van Maldergem L; Martin JJ; Van Broeckhoven C
    Brain; 1999 Feb; 122 ( Pt 2)():281-90. PubMed ID: 10071056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
    Young P; Grote K; Kuhlenbäumer G; Debus O; Kurlemann H; Halfter H; Funke H; Ringelstein EB; Stögbauer F
    J Neurol; 2001 May; 248(5):410-5. PubMed ID: 11437164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
    Eggers SD; Keswani SC; Melli G; Cornblath DR
    Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene.
    Chapon F; Latour P; Diraison P; Schaeffer S; Vandenberghe A
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):779-82. PubMed ID: 10329755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met.
    Senderek J; Hermanns B; Lehmann U; Bergmann C; Marx G; Kabus C; Timmerman V; Stoltenburg-Didinger G; Schröder JM
    Brain Pathol; 2000 Apr; 10(2):235-48. PubMed ID: 10764043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset Charcot-Marie-Tooth 2 syndrome caused by two novel mutations in the MPZ gene.
    Auer-Grumbach M; Strasser-Fuchs S; Robl T; Windpassinger C; Wagner K
    Neurology; 2003 Nov; 61(10):1435-7. PubMed ID: 14638973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset Charcot-Marie-Tooth type 1B disease caused by a novel Leu190fs mutation in the myelin protein zero gene.
    Kochański A; Kabzińska D; Drac H; Ryniewicz B; Rowińska-Marcińska K; Hausmanowa-Petrusewicz I
    Eur J Paediatr Neurol; 2004; 8(4):221-4. PubMed ID: 15261887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene.
    Marrosu MG; Vaccargiu S; Marrosu G; Vannelli A; Cianchetti C; Muntoni F
    Neurology; 1998 May; 50(5):1397-401. PubMed ID: 9595994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of the myelin protein zero gene in patients with Charcot-Marie-Tooth disease.
    Nowakowski A; Kochański A
    Acta Biochim Pol; 2004; 51(1):273-80. PubMed ID: 15094849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset axonal Charcot-Marie-Tooth phenotype caused by a novel myelin protein zero mutation.
    Bienfait HM; Faber CG; Baas F; Gabreëls-Festen AA; Koelman JH; Hoogendijk JE; Verschuuren JJ; Wokke JH; de Visser M
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):534-7. PubMed ID: 16543539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
    Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
    Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes.
    Street VA; Meekins G; Lipe HP; Seltzer WK; Carter GT; Kraft GH; Bird TD
    Neuromuscul Disord; 2002 Oct; 12(7-8):643-50. PubMed ID: 12207932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the Myelin Protein Zero result in a spectrum of Charcot-Marie-Tooth phenotypes.
    Kochański A
    Acta Myol; 2004 May; 23(1):6-9. PubMed ID: 15298082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia.
    Luigetti M; Modoni A; Renna R; Silvestri G; Ricci E; Montano N; Tasca G; Papacci M; Monforte M; Conte A; Pomponi MG; Sabatelli M
    Clin Neurol Neurosurg; 2010 Nov; 112(9):794-7. PubMed ID: 20537790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.